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Background: To determine the relationship of 
Forced Expiratory Volume in first second (FEV1) 
with pulmonary arterial pressure among patients 
with chronic obstructive airway disease.  
Methods:  In this cross sectional study  276 
patients, using -0.17 correlation between FEV1 and 
pulmonary artery pressure with 95% confidence 
level and 80% power of test, were enrolled .  All 
patients 40 years or above, diagnosed with COPD of 
minimum duration 3 years were included. Doppler 
Echocardiography for the measurement of 
pulmonary arterial pressure was done. All the 
patients were also subjected to spirometery for the 
measurement of forced expiratory volume in one 
second.  Spearman’s RANK correlation test was 
applied to see the relationship between FEV1 and 
pulmonary arterial pressure. P value of < 0.05 was 
considered significant.   
Results: Mean age was 63.94+10.11 years. Mean 
duration of COPD was 13.19+5.15 years. The mean 
FEV1 (percent predicted) was 32.84+13.43.  Among 
these 276 patients, 133 (48%) patients had Pulmonary 
Hypertension (PH). The mean PAP was 61.99 + 14.33. 
The correlation was calculated between FEV1 and 
PAP by using Pearson Correlation Coefficient and 
was found to be –0.406 (p=0.000). 
Conclusion: Increase in severity of COPD (as 
measured by falling FEV1) is strongly correlated 
with increasing severity of pulmonary artery 
pressure and thus warrants echocardiographic 
screening of COPD cases with mild to very serious 
disease.  
Key Words: Chronic obstructive airway 
disease(COAD), Pulmonary hypertension(PH), 
Forced expiratory volume in one second(FEV1).   
Introduction 
Chronic Obstructive airway disease (COAD) is 
considered as  the 4th major cause for death and it is 
estimated to become the most common disease 
affecting mankind by year 2020. One established 
complication of COPD is the development of 
pulmonary hypertension (PH).1 The pathophysiology 
involves hypoxic pulmonary vasoconstriction which 
results in remodeling and narrowing of lumen of 
vessels. Under these circumstances right side of heart 
need to increase the pumping pressure in order to 
overcome the pulmonary vascular resistance. As this 
pathology worsens, a condition develops which is 
called“cor-pulmonale”. When patients develop this 
condition the mortality and morbidity increases and 
five-year survival ranges from 20% to 36%.  Apart 
from the disease process itself, there is also 
contribution of worsening pulmonary hypertension 
and increasing age.2COAD is considered one of the 
most common cause of pulmonary hypertension 
worldwide.3  Frequency of pulmonary hypertension 
among these cases has been reported around 53% in 
literature.4 So far the accepted definition of pulmonary 
hypertension is pulmonary artery pressure (PAP)  of 
more than 25 mm Hg along with a pulmonary 
capillary wedge pressure (PCWP)<15 mm Hg, LA (left 
atrial) pressure or left ventricular (LV) end diastolic 
pressure of less than15 mm Hg.5 
Right ventricular catheterization is considered to be a 
gold standard method for diagnosing the PH 
(pulmonary hypertension). Transthoracic echo-
cardiography is very useful and relatively noninvasive 
technique for measuring pulmonary arterial pressure 
as it is frequently used for screening and monitoring 
disease progression. It is widely available, cheaper 
with sensitivity and specificity of 83% and 72% 
respectively.6 Although medical diagnostics and 
therapeutics are improving day by day treating PH 
still remains a therapeutic challenge with increased 
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mortality and morbidity as having one year survival 
rate of 53%. A patient who has advanced disease and 
is not a candidate for medical therapy, an alternate 
option is lung transplant.7Pulmonary arterial pressure 
showed an inverse relationship with FEV1but no 
relationship with resting PO2. FEV1 has been shown to 
be strongly negatively correlated with pulmonary 
artery pressure (r = -0.63)8but in another study it 
showed insignificant correlation (r =-0.17).8,9 
 
Patients and Methods 
This cross sectional study was done over six months 
period at Fauji Foundation Hospital Rawalpindi. 
Sample size was 276 patients, using -0.178 correlation 
between FEV1 and pulmonary artery pressure with 
95% confidence level and 80% power of test. All 
patients 40 years or above, diagnosed COPD with 
minimum duration of 3 years of both gender were part 
of the study. Conditions mimicking COPD like 
asthma, bronchiectasis and congestive heart failure 
were excluded. Conditions causing pulmonary artery 
hypertension other than COPD like interstitial lung 
diseases and primary pulmonary hypertension were 
also excluded. The Doppler Echocardiography for the 
measurement of pulmonary arterial pressure was done 
for all patients in the radiology department. All the 
patients were also subjected to spirometery for the 
measurement of forced expiratory volume in one 
second. Data was entered and analyzed by SPSS 
version 15.0. Frequency / percentage were calculated 
for qualitative variable like gender. Mean + standard 
deviation of quantitative variable like age was 
calculated. Spearman’s RANK correlation test was 
applied to see the relationship between FEV1 and 
pulmonary arterial pressure. P value of < 0.05 was 
considered significant.  
 
Results 
In this study a total of 276 patients were observed to 
determine the correlation between Forced Expiratory 
Volume in first second and Pulmonary Artery 
Pressure in patients with Chronic Obstructive 
Pulmonary disease. Thirty two (11.59%) patients were 
in age range 40-50 years, 107(38.76%) patients were in 
age range 51-60 years, 84(30.43%) patients were in age 
range 61-70 years, 46(16.66%) patients were in age 
range 71-80 years and 7(2.53%) patients were above 80 
years of age. Mean age was 63.94 years with SD 
±10.11.One hundred and twenty six  (45.6%) patients 
were male while 150(54.3%) patients were female. 
Eleven 11(4%) had COPD from 4-6 years,105(38%) had 
COPD from 7-10 years and 160(58%) had COPD for> 
10 years. Mean duration of COPD was 13.19 years 
with SD ± 5.15.  Three (1%) had mild FEV1  (more than 
80%),27(10%) had moderate FEV1  (50-79%), 102(37%) 
had severe FEV1 (from 30-49% and 144(52%) had very 
severe FEV1 (< 30%).  Mean FEV1 was 32.84% with 
standard deviation ± 13.43.  Mean FEV1 was 32.84 with 
SD± 13.43. Association of PAP by using Pearson 
Correlation Coefficient and was found to be –0.406 
(P=O.OOO) (Table 1). One hundred and thirty three  
patients had PAP in which n=17(13%) patients had 
mild PAP ranged from 30-50 mmHg, n=85(64%) 
patients had moderate PAP 51-70 mmHg) and 31(23%) 
patients had severe PAP (more than 70 mmHg). Mean 
PAP was 61.99 ± 14.33mmHg . Status of FEV1 findings 
in patients with raised Pulmonary arterial pressure 
was analyzed among 133 patients having PAH; 8(6%) 
had moderate COPD(FEV1 ranged from 50-
79),44(33%) had severe COPD (FEV1 ranged from 30-
49) and 81(61%) had very severe COPD (Table 2).No 
patient with mild COPD had PAH and as the severity 
of COPD increases the frequency of patients without 
PAH decreases. 
 
Table  1: Correlation between  FEV1 and  PAP(n=133) 
  Forced Expiratory 

























Table  2: Forced expiratory volume in first Second- 
pulmonary artery pressure Cross tabulation(n=133) 
 
Pulmonary Artery Pressure  





Moderate  7 1 8 
Severe 8 24 12 44 
Very 
severe 
9 54 18 81 
Total 17 85 31 133 
 
Discussion 
Chronic obstructive airway disease is now considered 
to be an underestimated common public problem all 
over the world. It is well proven that it can be 
prevented and its morbidity and mortality can be 
decreased easily.  In USA and Canada the incidence of 
chronic airway disease is around 3% to 17% while in 
most of underdeveloped world the disease incidence is 
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much greater and range from 13% to 27%.10 The 
prevalence of COAD with combination of its mortality 
and morbidity was found twelfth highest level 
worldwide in 1990 and it is estimated to rise at level 
third by year 2020, with five times more deaths than in 
year 1990.11 The effects of COAD on heart are 
contributing in worse prognosis of these patients. 
COAD effects the functioning of right ventricle and 
atrium which leads to increase in pulmonary vascular 
resistance and gradually this condition complicates the 
disease process of COAD which co-relates inversely 
with survival. There are a lot of structural 
abnormalities found in pulmonary vasculature among 
patients with COAD.12 As the arterial oxygen 
concentration decreases it results in increased 
thickening of intima and hypertrophy of vascular wall 
of small branches of the pulmonary arteries. Along 
with these changes in pathology there is pulmonary 
vascular constriction which arises due to alveolar 
hypoxia, damage to pulmonary vasculature bed, 
change in the intrinsic vasodilators in lungs (such as 
decrease in prostacyclin synthase, endothelial nitric 
oxide synthase and an increase in endothelin 1 will 
lead to remodeling of vessels, an increase of blood 
viscosity, and changes in respiratory cycle. All these 
changes will result in lung arterial vessel resistance 
which results in an increase in pulmonary 
hypertension.13  
Severe pulmonary hypertension results in increase of 
right ventricular pressures which lead to rise in right 
ventricular workload resulting in right ventricular 
hypertrophy. In patients with COAD this pulmonary  
vascular constriction leads to increased right 
ventricular mass but also result in dilatation of right 
ventricular which ultimately leads to clinical condition 
of cor-pulmonale.14 Although the exact incidence of 
pulmonary hypertension in patients with COAD is not 
well known, elevated pulmonary vascular pressure is 
described to occur in 20%–90% of cases by measuring 
with right heart catheterization along with evidence of 
worsening pulmonary hemodynamic with increasing 
airflow obstruction. In our study there was slight 
female predominance with 54.3% females affected and 
45.6% males affected. This difference in gender 
distribution of COPD was due to lower socioeconomic 
status of families with more use of biofuel mass for 
cooking and heating processes and lack of proper 
ventilation and education.  
Data of present study reveals that majority of patients  
got admitted with severe to very severe COPD while 
patients with mild to moderate diseases were  usually 
treated as OPD cases. On the other hand 133 patients 
had PH out of which 17(13%), 85(64%) and 31(23%) 
had mild (PAP=30 to 50 mmHg), moderate (PAP=50 to 
70mmHg) and severe PH (PAP > 70 mmHg) 
respectively. Our study shows that FEV1 is inversely 
proportional to PAP. The correlation coefficient 
between FEV1 and PAP turned out to be r= -0.406 
(p=0.000) suggesting that as disease gets severe 
(marked by falling FEV1) pulmonary artery pressure 
rises. Similar findings were observed in other studies 
done by Fishman A et al 14 in which FEV1 had shown 
to be strongly negatively correlated with pulmonary 
artery pressure (r = -0.63) in another study done by 
Thabut G et al  15shows insignificant correlation (r = - 
0.17). 15 
In our study it was found that abnormal rise in mean 
pulmonary vascular pressures leading to development 
of pulmonary hypertension was seen only in severe 
cases of COAD, which also corresponds with 
international literature that incidence and severity of 
pulmonary hypertension is directly proportional to 
severity of disease. Previous studies showed the 
frequencies of severe PH in COPD from about 1%–
3%16,but in our study it is 11% (n=31) out of the total 
study population. 16 Out of these 11%, 4.7% (n=13) had 
left heart failure while 1% (n=3) had chronic 
thromboembolic disease, which are additional causes 
of PH, and only 5.4% (n=15) had severe PH secondary 
to COPD as the only cause for severe PH. In our study 
no case with mild COPD had PH. In addition severe 
PH (PAP>70mmHg) is found predominantly in cases 
with severe and very severe COPD. These data 
suggest that if PH is found in mild cases of COPD and 
if severe PH registered in cases with moderate COPD 
then such cases should be evaluated further for 
additional causes of PH such as idiopathic PH or 
chronic pulmonary thromboembolism disease etc. In 
our study right ventricular failure was seen in 28% of 
patients while in literature about 25% patients with 
COAD eventually develop cor- pulmonale. It is well 
established that about 10 to 30 percent of hospital 
cardiac admission in USA every year are due to cor-
pulmonale and about 85% patients with cor-
pulmonale have COAD. Although there are some 
studies which indicate that left ventricular function 
remains normal in persons with COAD, most of 
literature suggest that it is definitely present.17 In 
present study, dysfunction of left ventricle was found 
in 7.5% patients while in previous literature it was 
found in about 14 to 28% patients of COAD.18 In 
another study left ventricular diastolic dysfunction 
was found in COAD patients with normal pulmonary 
vascular pressure and it was found to increase with 
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right ventricular afterload, while in our study LV 
dysfunction was present in about 47.5% patients, out 
of which only 16% patients had pulmonary 
hypertension. 19 There are various pathologies which 
might explain presence of left ventricular diastolic 
dysfunction in COAD patients like chronic hypoxemia 
leading to abnormal myocardial relaxation, lung 
hyperinflation and distension which leads to increased 
stiffness of the parietal pleura as well as wall of 
cardiac fossa leading to added load on ventricle and 
also due to ventricular interdependence. In our 
research LV hypertrophy was there in about 22% 
patients while in one previous study LVH was found 
in 25% patients who also had right ventricular 
hypertrophy.19 
Conclusion 
1.Increase in severity of patients with chronic 
obstructive airway disease (COAD) as measured by a 
fall in FEV1 is strongly correlated with increasing 
severity of pulmonary artery pressure with eventual 
increased morbidity and mortality.  
2.Right ventricular dysfunction is present in majority 
of these patients with severe COAD with or without 
some element of left ventricular dysfunction.  
3.Findings of present study warrants 
echocardiographic screening of COPD patients with 
moderate to very severe diseases.  
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